Updates: Indian Patents

New Drug Compounds Sun Pharmaceuticals secured an Indian Patent No. 204126 (the ‘126 patent) titled 4-(Diarylmethyl)-1-piperazinyl derivatives against its application number 302/MUM/2002 (Equivalent US Publication No. 20050107393). World’s leading pharma major Pfizer obtained an Indian Patent No. 204132 (the ‘132 patent) titled CCR5 Modulator Compounds against its application number 885/MUM/1999 (Equivalent US Patent Nos. 6,586,430 and 7,041,667) and an Indian Patent No. 204344 titled 1-Thifluoromethyl-4-Hydroxy-7-Piperidinylaminomethylchroman derivatives against its application number 456/MUM/2000 (Equivalent US Patent No. 6,239,147). Janssen Pharmaceutica N.V. received an Indian Patent No. 204144 (the ‘144 patent) titled Benzimidazoles and imidazopyridines having Inhibitory Antiviral Activity against its application number IN/PCT/2001/01539/MUM. Glaxo secured an Indian Patent No. 204151 (the ‘151 patent) titled Substituted oxazoles and thiazoles derivatives as HPPAR ALPHA Activators against its application number IN/PCT/2002/00583/MUM. World’s third largest company AstraZeneca obtained an Indian Patent No. 204158 (the ‘158 patent) titled Imidazo Pyridine Derivatives which inhibit Gastric Acid Secretion against its application number IN/PCT/2000/00496/MUM (Equivalent US Patent Nos. 6,313,136 and 6,313,137). New Form Pfizer secured an Indian Patent No. 204325 (the ‘325 patent) titled An Eletriptan Hydrobromide Monohydrate and a process for the preparation of the same against its application number 841/MUM/1999. Pfizer obtained an Indian Patent No. 204343 (the ‘343 patent) titled Polymorph of (2R, 3S, 4R, 5R, 8R,10R, 11R, 12S, 13S,14R)- 13- [[2,6-dideoxy-3-cmethyl-3-0-methyl-4-(-[(propylamino)methyl]-a-l- ribohexopryanosyl]- 2-ethyl-3,4,10- trihydroxy-3,5,8,10,12,14-examethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)- b-d-xylohexopyranosyl] oxa]-1-oxa-6-azacycopentadecan-15-one diphosphate